Encision Osake

Encision AAQS

AAQS yhtiöstä Encision (ECIA) 5.8.2026 päivämäärällä on 2. Edellisenä vuonna AAQS oli 2,00 — muutos 0,00 % (matalampi).

AAQS

2

YoY

0,00%

Viimeksi päivitetty:

Encision:lla on nykyään AAQS arvo 2. Korkea AAQS voidaan nähdä positiivisena merkkinä siitä, että yritys kehittyy onnistuneesti. Sijoittajat voivat odottaa, että yritys on hyvällä tiellä tuottamaan voittoa. Toisaalta on tärkeää verrata osakkeen Encision AAQS:ää saavutettuihin voittoihin ja samaan toimialaan kuuluviin muihin yrityksiin. Korkea AAQS ei ole absoluuttinen takuu positiivisesta tulevaisuudesta. Vain sillä tavalla voi saada kattavan kuvan yrityksen suorituskyvystä. Yrityksen kehityksen arvioimiseksi on tärkeää tarkastella AAQS:ää suhteessa toimialan muihin yrityksiin. Yleisesti ottaen sijoittajien tulisi aina tarkastella yrityksen AAQS:ää yhdessä muiden tunnuslukujen, kuten voiton, EBIT:n, kassavirran ja muiden kanssa, jotta he voivat tehdä perustellun sijoituspäätöksen.
Access this data via the Eulerpool API

Encision Osakeanalyysi

Mitä Encision tekee? Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado. The company's history can be traced back to 1991 when it was founded by Kenneth Messier, an experienced surgeon. At that time, minimally invasive surgery was becoming increasingly popular as it offered patients smaller scars and less pain. However, the technology was not yet perfected and problems, particularly with the use of high-frequency electrocautery, kept arising. Messier recognized this problem and developed an innovative solution: AEM technology (Active Electrode Monitoring). Together with a colleague, Mark Weinstein, he founded Encision Inc to bring this technology to the market. Since then, the company has evolved into a leading provider of precision tools for minimally invasive surgery. Encision's business model is based on the production and distribution of medical devices and related consumables. Encision offers a wide range of surgical instruments, including AEM and non-AEM electrocautery devices, surgical monitors, fine cutting instruments, and trocars. These devices are used in various surgical disciplines such as gynecology, urology, and general medicine. One of Encision's main areas of focus is AEM technology, which reduces the risk of unintentional tissue burns during electrocautery. The AEM system continuously monitors the electrical impedance of the tissue and adjusts the high-frequency power as needed. Another important area for Encision is the development of disposable products such as electrodes, needles, and tubing sets. These products are intended for single-use and help minimize infection risks. Encision has also specialized in the development of instruments for laparoscopic surgery, a minimally invasive technique in which the operation is performed through small incisions in the body. Encision's laparoscopy instruments offer precise control and high performance to meet the demands of surgeons. Encision has sold over 2,500 devices to clinics and healthcare providers in North America and Europe. Most of the products are registered and certified in the USA. Encision places great emphasis on quality and innovation. The company has strict quality control measures to maintain the highest standards in production and the development of new products. Furthermore, it is committed to constantly developing new technologies and expanding its portfolio to meet customer needs. Overall, Encision Inc has experienced strong growth in recent years and has become a leading provider of surgical instruments in the minimally invasive surgery industry. With its focus on quality, innovation, and customer satisfaction, the company has built a solid reputation in the industry and is expected to continue being a key player in the future. The answer is "Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado." Encision on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Encision osakkeesta

Yhtiön Encision AAQS on 2 vuonna 2026.

Eurpoolissa voit löytää AAQS Encision:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

AAQS on AlleAktienin kehittämä tunnusluku.

AAQS on AlleAktienin kehittämä tunnusluku.

Access this data via the Eulerpool API

Laatu — Encision

Kaikki tunnusluvut — Encision